 OUTLINE: This is a multicenter study. Patients are stratified according to participating center, T stage T3 vs T4, tumor localization measured from caudal part of the tumor to the anocutaneous line 10 cm vs 10 cm, and number of EGFR gene copies 2.9 vs 2.9. Patients are randomized to 1 of 2 treatment arms. 